Alex Zhavoronkov, PhD (IMAGE)

InSilico Medicine

Alex Zhavoronkov, PhD

Caption

Insilico Medicine founder and CEO Alex Zhavoronkov, PhD will discuss how artificial intelligence is transforming drug discovery as part of the World’s Top 50 Innovators, presented September 26-28 by Codex in London.

Credit

Insilico Medicine

Usage Restrictions

none

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.